Skip to main content
. 2021 May 27;16(5):e0251754. doi: 10.1371/journal.pone.0251754

Table 1. Clinical characteristics of study participants by mortality.

  Non-Survivors Survivors
n(%) n(%)
Age (years)    
≤60 24 (35.8) 64 (62.1)
>60 43 (64.2) 39 (37.9)
Gender
Male 52 (77.6) 81 (78.6)
Female 15 (22.4) 22 (21.4)
Symptoms
Fever 54 (80.6) 86 (63.5)
Cough 40 (59.7) 62 (60.2)
SOB 57 (85.1) 83 (80.6)
Runny nose 1 (1.5) 3 (2.9)
Sore Throat 3 (4.5) 4 (3.9)
Chest Pain 5 (7.5) 2 (1.9)
Fatigue 8 (11.9) 5 (4.9)
Diarrhea 4 (6.0) 8 (7.8)
Vomiting 2 (3.0) 10 (9.7)
Others 13 (19.4) 26 (25.2)
Duration of symptoms* (days) 6 (4–7) 7 (4–10)
Comorbid conditions
None 13 (19.4) 38 (36.9)
Hypertension 35 (52.2) 39 (37.9)
Diabetes 35 (52.2) 41 (39.8)
Liver Disease 1 (1.5) 0 (0)
Lung Disease 3 (4.5) 3 (2.9)
Renal Disease 6 (9.0) 7 (6.8)
Heart Disease 7 (10.4) 10 (9.7)
Other 12 (17.9) 26 (25.2)
Number of comorbid conditions
< = 2 43 (79.6) 45 (69.2)
3 or more 11 (20.4) 20 (30.8)
Clinical Signs at presentation
Systolic Blood pressure* (mm/Hg) 144 (123–159) 135 (122–149)
Diastolic Blood pressure* (mm/Hg) 80 (68.5–95) 79 (72.5–89)
Pulse**/minute 104.0 ± 22.0 101.1 ±20.3
Respiratory Rate*/m 32 (26–38) 28 (23–32)
Temperature* °F 98.6 (98–99.0) 98.4 (98–98.6)
Oxygen Saturation (%)
≥93% 13 (19.4) 46 (44.7)
<93% 54 (80.6) 57 (51.4)
Glasgow Coma Scale 15 (15–15) 15 (15–15)
Disease Severity
Moderate 0 (0) 18 (17.5)
Severe 3 (4.5) 12 (11.7)
Critical 64 (95.5) 73 (70.9)
Non-invasive ventilation in emergency room
Yes 38 (56.7) 27 (26.2)
No 29 (43.3) 76 (73.8)
Clinical Severity Scores
SOFA score* 6 (5–8.2) 4 (4–6)
CURB-65 score* 2 (1–3) 1 (0–2)
MuLBSTA* 7.5 (6–9.5) 5 (2–8)
Month of admission
March 4 (5.9) 2 (1.9)
April 22 (32.8) 28 (27.4)
May 32 (47.8) 46 (45.1)
June 9 (13.4) 26 (25.5)

*Median (Q1-Q3)

**Mean±SD.